Randhawa Simrat bought DNTH
January 24, 2024 · Form 4 insider transaction
Randhawa Simrat bought 120,000 shares of Dianthus Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
120,000
Price
$0.00
Total value
N/A
InsiderRandhawa Simrat
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 24, 2024
Filing dateJanuary 26, 2024
Shares owned after120,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.